Prader-willi syndrome Trials in Mineola, United States
Conditions / Prader-willi syndrome / Mineola, United States
Prader-willi syndrome has been the subject of sustained clinical investigation across multiple research sites.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT07197034 | The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial | RECRUITING | PHASE3 |
| NCT03714373 | Open-Label Extension Study of DCCR in PWS Followed by Double-Blind, Placebo-Controlled, Randomized Withdrawal Period | COMPLETED | PHASE3 |
| NCT05701774 | Open-Label Extension Study of DCCR in Patients With Prader-Willi Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03790865 | Effects of Livoletide (AZP-531) on Food-related Behaviors in Patients With Prader-Willi Syndrome | TERMINATED | PHASE2/PHASE3 |
| NCT03440814 | A Study of Diazoxide Choline in Patients With Prader-Willi Syndrome | COMPLETED | PHASE3 |
| NCT02311673 | Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome | COMPLETED | PHASE2 |
| NCT02179151 | Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome | TERMINATED | PHASE3 |
| NCT06828861 | ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial | RECRUITING | PHASE3 |
| NCT05322096 | Study to Evaluate Efficacy, Safety, and Tolerability of RGH-706 in Prader-Willi Syndrome | COMPLETED | PHASE2 |
| NCT02381457 | SNP-based Microdeletion and Aneuploidy RegisTry (SMART) | COMPLETED | — |